SM
AMPE

Sabby Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Sabby Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5
Closed -$497 – 296
2014
Q3 		$497 Sell
5
-1
-17% -$1.68K 0.02% 182
2014
Q2 		$1.5M Hold
6
– – 0.06% 124
2014
Q1 		$1.06M Buy
6
+5
+500% +$11.8K 0.06% 134
2013
Q4 		$275K Buy
+1
New +$2.36K 0.02% 176

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Sabby Management's AMPE Position: Q3 2019 in Review

Sabby Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2019, closing a stake of 17,551 shares — an estimated $2.04M sold.

Sabby Management first reported a position in AMPE in Q4 2013 and held it in 5 quarters. The position peaked at $2.04M in Q2 2019. 75 funds tracked by Wall St. Rank hold AMPE as of Q3 2019.

  • Sabby Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2019 after selling out during the quarter.
  • Sabby Management sold 17,551 Ampio Pharmaceuticals Inc. shares in Q3 2019, an estimated $2.04M.
  • Sabby Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 5 quarters.
  • Sabby Management's Ampio Pharmaceuticals Inc. position peaked at $2.04M in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2019.

Based on Sabby Management's 13F filing for Q3 2019, filed 15 Nov 2019.